Skip Navigation

Medical Product Safety

Baseline: 60.7 percent percent of medical-surgical hospitals reported adverse drug events in 2009
Target: 66.8 percent
Target-Setting Method: 10 percent improvement
Data Source: National Survey of Pharmacy Practice in Hospital Care Settings, American Society of Health-System Pharmacists (ASHP)
Data:
Data for this objective HP2020 data for this objective
Data Details Details about the methodology and measurement of this HP2020 objective
Healthy People 2010 HP2010 data for this objective
More Information:
Related research articles on PubMed
Close Details
MPS-2     Increase the safe and effective treatment of pain
Baseline: 575 non-FDA-approved pain medications (opioids, nonsteroidal anti-inflammatory drugs [NSAIDs], and acetaminophen used to treat pain) were on the market in 1 year beginning January 2007
Target: 518 non-FDA-approved pain medications
Target-Setting Method: 10 percent improvement
Data Sources: FDA Drug Registration and Listing Database, FDA; Electronic database of prescription sales in the US, Intercontinental Marketing Services (IMS)
Data:
Data for this objective HP2020 data for this objective
Data Details Details about the methodology and measurement of this HP2020 objective
More Information:
Related research articles on PubMed
Close Details
MPS-5     Reduce emergency department (ED) visits for common, preventable adverse events from medications
Baseline: 35.9 ED visits per 10,000 outpatient prescription visits for overdoses from oral anticoagulants occurred in 2006–07
Target: 32.3 ED visits per 10,000 outpatient prescription visits
Target-Setting Method: 10 percent improvement
Data Sources: National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES), CDC and CPSC and FDA; National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC/NCHS; National Ambulatory Medical Care Survey (NAMCS), CDC/NCHS
Data:
Data for this objective HP2020 data for this objective
Data Details Details about the methodology and measurement of this HP2020 objective
More Information:
Related research articles on PubMed
Close Details
Baseline: 43.4 ED visits per 10,000 outpatient prescription visits for overdoses from injectable antidiabetic agents occurred in 2006–07
Target: 39.1 ED visits per 10,000 outpatient prescription visits
Target-Setting Method: 10 percent improvement
Data Sources: National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES), CDC and CPSC and FDA; National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC/NCHS; National Ambulatory Medical Care Survey (NAMCS), CDC/NCHS
Data:
Data for this objective HP2020 data for this objective
Data Details Details about the methodology and measurement of this HP2020 objective
More Information:
Related research articles on PubMed
Close Details
Baseline: 8.9 ED visits per 10,000 outpatient prescription visits for overdoses from narrow-therapeutic-index medications occurred in 2006–07
Target: 8.0 ED visits per 10,000 outpatient prescription visits
Target-Setting Method: 10 percent improvement
Data Sources: National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES), CDC and CPSC and FDA; National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC/NCHS; National Ambulatory Medical Care Survey (NAMCS), CDC/NCHS
Data:
Data for this objective HP2020 data for this objective
Data Details Details about the methodology and measurement of this HP2020 objective
More Information:
Related research articles on PubMed
Close Details
Baseline: 32.7 ED visits per 10,000 children less than 5 years of age occurred in 2007–08
Target: 29.4 ED visits per 10,000 children less than 5 years of age
Target-Setting Method: 10 percent improvement
Data Sources: Population Estimates, Census; National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES), CDC and CPSC and FDA
Data:
Data for this objective HP2020 data for this objective
Data Details Details about the methodology and measurement of this HP2020 objective
More Information:
Related research articles on PubMed
Close Details

Back to Top